Navigation Links
Study suggests caution and further studies on drugs used to treat macular degeneration
Date:10/25/2012

LA JOLLA, CA October 24, 2012 Millions of people with "wet" macular degeneration are prescribed a class of medication known as anti-VEGF drugs. But now scientists at The Scripps Research Institute (TSRI) have found that a drastic reduction of VEGF activity may do more harm than good.

In the new study, the researchers deleted the gene for the blood-vessel growth factor VEGF, which has been implicated in stimulating abnormal blood vessel growth in a range of cancers and eye diseases, from cells in the retinas of adult mice. The results showed that without VEGF a large subset of light-sensing cells lost their main blood supply and shut down, causing severe vision loss.

"It's becoming clear that VEGF has a critical function in maintaining the health of the retina, and we need to preserve that critical function when we treat VEGF-related conditions," said TSRI Professor Martin Friedlander, MD, PhD, senior author of the new study, which appears in the November 2012 issue of the Journal of Clinical Investigation.

Major Target for Drug Developers

VEGF (vascular endothelial growth factor) has long been a major target for drug developers. Tumors often overproduce VEGF to stimulate local blood vessel growth and thus keep their fast-dividing cells well supplied with oxygen and nutrients. Low-oxygen conditions in the eyes of elderly or diabetic individuals also can trigger the overproduction of VEGF, resulting in a vision-destroying bloom of abnormal, leaky retinal blood vessels.

Several anti-VEGF drugs (such as Lucentis (ranibizumab), Macugen (pegaptanib), Eylea (aflibercept) and Avastin (bevacizumab)) are already in use, and dozens more are in clinical trials against cancers and common eye disorders such as wet macular degeneration.

However, to date there have not been extensive studies on the effects of such drugs on the normal role of VEGF, in part because it is hard to generate adult animals that l
'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Fossil study helps pinpoint extinction risks for ocean animals
2. Forest killer plant study explores rapid environmental change factors
3. Pitt biologist receives $2 million to study genetic diversity of plants worldwide
4. Study: DNA barcoding can ID natural health products
5. Joint UT study: Reading food labels helps shoppers stay thinner
6. Sandia shows monitoring brain activity during study can help predict test performance
7. New study confirms erroneous link between XMRV and prostate cancer-contamination was the cause
8. The George Washington University Researcher received $1.7 million to study solar cement
9. Risk of developing diabetes higher in neighborhoods that arent walk-friendly: Study
10. Rice to take part in $10.8 million study of hemoglobin toxicity
11. Einstein researcher receives $10.8 million grant to study toxic blood reactions caused by hemoglobin
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study suggests caution and further studies on drugs used to treat macular degeneration
(Date:7/10/2014)... or even improve the state of fisheries resources ... the Mediterranean has deteriorated over the past 20 ... species reported in the Cell Press journal ... for stringent monitoring of Mediterranean fishing activities, better ... in Mediterranean waters. , Their data show that ...
(Date:7/10/2014)... for Interdisciplinary Research (MIIR) and the Marshall University ... they will be partnering with an international biosciences ... the agreement with Shanghai-based HD Biosciences Co. Ltd., ... risks of discovery and development of these new ... property and commercialization rights to products developed through ...
(Date:7/10/2014)... incubator, received a $1.4 million federal grant to develop ... bleeding during brain surgery. , Surgeons can spray the ... solutions in the gel will cohere and control bleeding ... gel can shorten an intracranial surgery by 30- 45 ... patient,s skull to be open and less anesthesia, reducing ...
Breaking Biology News(10 mins):Mediterranean fish stocks show steady decline 2Marshall University to partner with international company in drug development venture 2A start-up at NJIT develops bleeding-control gel for brain surgery 2
... common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. ... a patient is likely to respond. And, unfortunately, picking the ... this month,s issue of the journal PLoS ONE , ... study used a sophisticated model of ovarian cancer genetics to ...
... Mass. A Navy-sponsored project to design a biologically inspired, swimming ... common bending rules for the tips of wings, fins, flukes, ... animal species. The study, led by John H. ... in Woods Hole, where he is a visiting scientist, is ...
... , , , , ... , AUDIO: Falon Tilley and ... Click here for more information. , ... , , , , ...
Cached Biology News:COXEN model picks the best drug for ovarian cancer 2Quest for jellyfish robot leads to discovery of bending rules for animal wing, fin tips 2Healthy Lunchbox Challenge helps influence healthy eating habits in children 2Healthy Lunchbox Challenge helps influence healthy eating habits in children 3Healthy Lunchbox Challenge helps influence healthy eating habits in children 4
(Date:7/10/2014)... 10, 2014 Terascala, the industry leader ... Alan Swahn, a former vice president of product management ... vice president of marketing. Terascala’s software when combined with ... create the highest performance and most reliable solutions for ... guide Terascala’s channel expansion and broaden its product portfolio. ...
(Date:7/10/2014)... July 10, 2014 Senior supply chain ... professional associations, addressed the challenges of “Reducing Cost, Lead ... Industries” through strategic sourcing. Describing the partnership of the ... Supply Chain Management Institute ( SCMI) of the ... June 24 at the Kroc Institute of Peace and ...
(Date:7/10/2014)... 10, 2014 Research and Markets ( ... "International Photonic Integrated Circuit (Monolithic Integration, Hybrid ... report to their offering. ... of photonic integration traces its roots in the ... of photonic integration went unexplored and unfulfilled for ...
(Date:7/10/2014)... the journal PNAS (Proceedings of the National Academy ... and sleep deprivation have a significant effect on our ... the best time of day to test for diseases ... medicines effectively. , Researchers from the University of Surrey ... links between sleep deprivation, body clock disruption and metabolism, ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Time of day crucial to accurately test for diseases, new research finds 2
... Genetics, Inc., (Pinksheets: VRAL) and its President, Haig Keledjian, ... with Timothy and Thomas LLC ("T&T") and its principals ... Settlement ends the almost 5-year-old lawsuit between the parties ... the Northern District of Illinois, originally initiated in March ...
... ANNAPOLIS, Md., Jan. 28, 2011 Anyone curious about ... plasma contributes to lifesaving medicines can now learn about ... Plasma Protein Therapeutics Association (PPTA). "Becoming a Plasma Donor," ... a committed plasma donor at one of the 400-plus ...
... This release is available in Spanish and ... observed for eons. From this fibrous diet consisting mainly of ... substances of no nutritional value to most animals, ruminants manage to ... keepers. And now, the cow, or rather the network ...
Cached Biology Technology:Viral Genetics Settles Litigation and Reacquires African Rights for HIV/AIDS Products 2Viral Genetics Settles Litigation and Reacquires African Rights for HIV/AIDS Products 3New Video on Plasma Donation Available 2How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 2How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 3How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 4How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 5
Shake 'n' Stack oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual)...
... - Neurosphere is a system designed for ... neurospheres in a serum free environment. The kit ... which has been optimized for neural stem cell ... Genes & Development 10 :3129). Two growth ...
Request Info...
... RQ1 RNase-Free DNase is a ... single-stranded or double-stranded DNA to produce ... for use in applications where maintaining ... RQ1 DNase is qualified for use ...
Biology Products: